MedTrace Logo

Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)

NCT01108588 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2015-08-13

No results posted yet for this study

Summary

This study will evaluate whether the antiplatelet effects of Aspirin 300 mg daily and Clopidogrel 75 mg daily can be reproducibly measured using several point of care platelet function assays

Conditions

  • Healthy Volunteers

Interventions

DRUG

Placebo (to match Aspirin)

Placebo grossly matched Aspirin 300 mg daily

DRUG

Aspirin

Aspirin 300 mg daily

DRUG

Clopidogrel

Clopidogrel 75 mg daily

DRUG

Comparator: Placebo (to match Clopidogrel)

Placebo (grossly matched Clopidogrel 75 mg) daily

Sponsors & Collaborators

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2010-08-31
Completion
2010-08-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01108588 on ClinicalTrials.gov